Fig. 1.
Design of multiphase trial showing nodal points at weeks 8 and 24. Note: the use of aripiprazole for risperidone non-responders. These subjects continued in their originally randomized group (medication only or medication plus PT)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.